Bicara Therapeutics(BCAX)
BOSTON, MABiotechnology
Focus: Bicara Therapeutics is a Boston-based public biotech company specializing in dual-action biologics and antibodies, primarily focused on oncology indications. The company operates at a mid-cap scale with a focused pipeline in head and neck squamous cell carcinoma.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Bicara Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Bicara Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PHASE_1
Ficerafusp alfa
Metastatic Head and Neck Squamous Cell CarcinomaClinical Trials (4)
Help build intelligence for Bicara Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.